Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients ...

In Phase III MINT trial, Uplizna (inebilizumab) demonstrated significant short-term efficacy and a manageable safety profile ...

In clinical studies, Ultomiris effectively improved the ability to carry out daily living activities in adults with generalized myasthenia gravis (gMG) who were anti-acetylcholine receptor (AChR ...

Nipocalimab-treated patients saw a 4.7-point improvement from baseline in the myasthenia gravis - activities of daily living (MG-ADL ... difference on the MG-ADL scale “may be the difference ...

Nipocalimab-treated patients saw a 4.7-point improvement from baseline in the myasthenia gravis - activities of daily living (MG-ADL) score in weeks 22, 23, and 24, compared to a 3.25-point ...

Nicholas J. Silvestri, MD, describes how this year’s AAN meeting highlighted significant advances in myasthenia gravis, including improved diagnostics through cell-based assays that enhance ...

The All Progressives Congress (APC) Uzo-Uwani local government area of Enugu state on Friday announced the suspension of Sen Chuka Utazi for alleged anti-party activities. Utazi, a two-time ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early ...